Cargando…
Impact of China’s zero mark-up drug policy on drug cost of NCDs’ outpatients: an interrupted time series analysis
BACKGROUND: China proposed the Zero Markup Drug Policy (ZMDP), which popularized in tertiary hospitals across the country in 2017, to control drug expenditures’ rapid growth further and reduce the public’s medical burden. This study aims to evaluate the impact of ZMDP on the drug cost of chronic dis...
Autores principales: | Du, Jielin, Xie, Jiajia, Qian, Yan, Wu, Mingyue, Huang, Wenjing, Yin, Jin, Peng, Xin, Deng, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086109/ https://www.ncbi.nlm.nih.gov/pubmed/33926444 http://dx.doi.org/10.1186/s12913-021-06414-3 |
Ejemplares similares
-
Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016–2018: an interrupted time series study in Shaanxi
por: Yan, Kangkang, et al.
Publicado: (2020) -
Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis
por: Wang, Junman, et al.
Publicado: (2020) -
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
por: Wang, Ruilin, et al.
Publicado: (2023) -
The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study
por: Zhu, Zheng, et al.
Publicado: (2022) -
Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis
por: Guo, Xirui, et al.
Publicado: (2023)